Delivery Order SPE2DB20D2104-SPE2DB24FU57F

Award Date 6/6/24
Potential Completion Date 6/7/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Enoxaparin 80 mg/0.8 mL syringes, a critical care medication. The contract has a ceiling value of $1,032.12 and an ultimate completion date of September 11, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,129.34, covers the supply of enoxaparin 120 mg/0.8 ml syringes. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 100 mg/mL enoxaparin syringes. The ceiling value of this firm-fixed-price contract is $1,085.28, with a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its role as a prime vendor for the DLA Troop Support Medical Indefinite Delivery Contract, valued up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Enoxaparin 150 mg/mL syringes. The $1,303.68 contract has a performance period through March 21, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under multiple DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,186.72, is for the delivery of Enoxaparin 80 mg/0.8 ml syringes. This is a firm-fixed-price delivery order with a completion date of January 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is a $3,855.67 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of 4566778739 Enoxaparin 120 mg/0.8 ml syringes, with an ultimate completion date of December 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order with the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Enoxaparin 150 mg/ml syringes. The award ceiling value is $1,999.73 and the ultimate completion date is March 27, 2024. The contract is not set aside for any specific business size or socioeconomic category. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,209.42 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of 100 mg/mL syringes of the anticoagulant medication enoxaparin, with a performance period through November 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,521.11 for the provision of 4,564,451 units of Enoxaparin 40 mg/0.4 ml syringes. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government entities. Amerisourcebergen, a major pharmaceutical distribution company, holds a large...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1X6, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565713260 - ENOXAPARIN 40 MG/0.4 ML SYR 0.4ML, with a ceiling value of $3,603.84 and a completion date of September 9, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU57F
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Enoxaparin 60 mg/0.6 ml syringes. The contract has a ceiling value of $2,277.16 and a completion date of June 7, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 12:47 PM